Community fever surveillance for incidence of Dengue and Chikungunya
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: B978- Other viral agents as the cause ofdiseases classified elsewhere
- Registration Number
- CTRI/2023/04/051805
- Lead Sponsor
- ational Biopharma Mission, Biotechnology Industry Research Assistance Council
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Individuals currently residing and likely to stay till the end of one year in the study area and consent to participate in both sections of the study (Sero Prevalence and AFI Surveillance) and follow all procedures
Exclusion Criteria
Ongoing fever episodes or history of AFI on or before enrolment for the cohort
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of AFI and lab confirmed dengue infection.Timepoint: After 12 months of follow up
- Secondary Outcome Measures
Name Time Method Incidence of lab-confirmed chikungunya infection.Timepoint: After 12 months of follow up